Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
India Glycols Limited (INDIAGLYCO.NS)
Noida, UP, IN
India Glycols Limited, a green petrochemical company, manufactures and sells industrial chemicals in India. It operates through Bio-based Specialities and Performance Chemicals, Potable Spirits, and Ennature Biopharma segments. The company offers bio mono ethylene, di ethylene, and tri ethylene glycols; ethyl/butyl glycol ethers and acetates, and brake fluids; bio-polymers comprising guar and natural gums; biofuels; specialty chemicals, such as plasticisers, oil fields chemicals, bio-amines, methyl soyate, MDEA and MDEA derivatives, bio-potash granules, and C-Smart specialty products; molasses and grain based extra neutral alcohol; and specialty gases, including industrial and medical oxygen, food grade and industrial carbon dioxide, liquid argon and nitrogen, ethylene oxide, and bio ethylene oxide. It also provides Indian made foreign liquor, such as whiskey under Soulmate Blu and Single Reserve brands; vodka under Amazing brand; and rum under Zumba and Beach House XXX brands, as well as economy spirits under Bunty brand, and branded country liquor. In addition, the company offers natural active pharmaceutical ingredients, nutraceuticals, standardized botanical extracts, and nicotine derivatives. Further, its products find applications in pharma and healthcare; textiles; automotive; personal care; industrial and manufacturing; paints and coatings; oil and gas; food ingredients; packaging; potable spirits; and other various industries. The company also exports its products. The company was formerly known as UP Glycols Limited and changed its name to India Glycols Limited in August 1986. India Glycols Limited was incorporated in 1983 and is headquartered in Noida, India.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| -0.81% | -3.71% | +3.79% | +5.12% | -7.25% | -0.51% | +17.75% | +226.39% | +307.37% | +2,225.21% | +3,121.80% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
-
Revenue growth Chemicals - Specialty: +4.7%+11.8% ★ Q1'26: +13.1% (vs Q1'25)
-
EPS growth Chemicals - Specialty: +13.2%+23.2% ★ Q1'26: +31.9% (vs Q1'25)
-
FCF margin FCF growth · Chemicals - Specialty: +44.1%+9.2% ★ Q1'26: -6.7% (vs Q1'25)
-
EBIT margin Chemicals - Specialty: +8.8%+11.7% ★ Q1'26: +12.8% (vs Q1'25)
-
ROIC Chemicals - Specialty: +5.6%+8.4% ★ Q1'26: +8.5% (vs Q1'25)
-
Share dilution Chemicals - Specialty: +0.1%+105.8% Q1'26: +105.8% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Chemicals - Specialty: 0.18×2.60× Q1'26: 2.54× (vs Q1'25)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Metric |
Mar 2012 actual |
Mar 2013 actual |
Mar 2017 actual |
Mar 2018 actual |
Mar 2019 actual |
Mar 2020 actual |
Mar 2021 actual |
Mar 2022 actual |
Mar 2023 actual |
Mar 2024 actual |
Mar 2025 actual |
Mar 2026 1 Rev. Ana. 1 EPS Ana. |
Mar 2027 1 Rev. Ana. 1 EPS Ana. |
Mar 2028 1 Rev. Ana. 1 EPS Ana. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue |
27.07B
est: 24.48B (+10.6%)
|
34.23B
est: 36.23B (-5.5%)
|
25.00B
est: 32.74B (-23.6%)
|
30.10B
est: 41.84B (-28.1%)
|
32.87B
est: 50.22B (-34.6%)
|
34.20B
est: 59.82B (-42.8%)
|
22.92B
est: 67.60B (-66.1%)
|
28.68B
est: 30.11B (-4.7%)
|
26.37B
est: 26.66B (-1.1%)
|
32.94B
est: 29.88B (+10.2%)
|
37.68B
est: 39.72B (-5.1%)
|
42.94B
42.94B – 42.94B
+8.1% YoY
|
46.97B
46.97B – 46.97B
+9.4% YoY
|
58.29B
58.29B – 58.29B
+24.1% YoY
|
| EBITDA |
3.40B
est: 3.41B (0.0%)
|
3.89B
est: 4.94B (-21.2%)
|
2.44B
est: 4.56B (-46.5%)
|
3.45B
est: 5.82B (-40.7%)
|
4.34B
est: 6.99B (-37.9%)
|
2.91B
est: 8.32B (-65.1%)
|
2.86B
est: 9.41B (-69.6%)
|
4.98B
est: 1.64B (+204.5%)
|
3.47B
est: 3.71B (-6.4%)
|
4.28B
est: 4.16B (+2.9%)
|
5.11B
est: 5.53B (-7.5%)
|
5.97B
5.97B – 5.97B
+8.1% YoY
|
6.54B
6.54B – 6.54B
+9.4% YoY
|
8.11B
8.11B – 8.11B
+24.1% YoY
|
| EBIT |
2.49B
est: 2.63B (-5.2%)
|
2.79B
est: 3.81B (-26.7%)
|
1.72B
est: 3.51B (-51.1%)
|
2.72B
est: 4.49B (-39.3%)
|
3.58B
est: 5.39B (-33.6%)
|
2.13B
est: 6.42B (-66.8%)
|
2.06B
est: 7.25B (-71.5%)
|
4.18B
est: 5.06B (-17.4%)
|
2.54B
est: 2.86B (-11.3%)
|
3.27B
est: 3.20B (+2.1%)
|
3.96B
est: 4.26B (-7.1%)
|
4.60B
4.60B – 4.60B
+8.1% YoY
|
5.04B
5.04B – 5.04B
+9.4% YoY
|
6.25B
6.25B – 6.25B
+24.1% YoY
|
| Net Income |
674.06M
est: 1.21B (-44.2%)
|
955.29M
est: 1.32B (-27.7%)
|
350.44M
est: 203.12M (+72.5%)
|
965.27M
est: 427.75M (+125.7%)
|
1.33B
est: 808.44M (+64.0%)
|
1.15B
est: 715.09M (+60.3%)
|
1.32B
est: 867.89M (+51.6%)
|
3.40B
est: 1.66B (+104.9%)
|
1.25B
est: 665.70M (+87.9%)
|
1.73B
est: 856.13M (+102.1%)
|
2.31B
est: 1.07B (+114.9%)
|
1.63B
1.63B – 1.63B
+51.7% YoY
|
2.01B
2.01B – 2.01B
+23.4% YoY
|
2.55B
2.55B – 2.55B
+26.9% YoY
|
| SGA |
1.29B
est: 1.25B (+2.9%)
|
2.30B
est: 1.81B (+26.7%)
|
1.58B
est: 1.67B (-5.5%)
|
1.22B
est: 2.14B (-42.8%)
|
1.32B
est: 2.56B (-48.3%)
|
1.26B
est: 3.05B (-58.8%)
|
1.41B
est: 3.45B (-59.2%)
|
2.26B
est: 4.59B (-50.8%)
|
1.13B
est: 1.36B (-17.0%)
|
1.30B
est: 1.52B (-14.6%)
|
1.23B
est: 2.03B (-39.5%)
|
2.19B
2.19B – 2.19B
+8.1% YoY
|
2.40B
2.40B – 2.40B
+9.4% YoY
|
2.97B
2.97B – 2.97B
+24.1% YoY
|
| EPS |
24.18
est: 39.00 (-38.0%)
|
32.46
est: 42.87 (-24.3%)
|
11.32
est: 6.56 (+72.6%)
|
31.18
est: 13.82 (+125.7%)
|
42.83
est: 26.11 (+64.0%)
|
37.03
est: 23.10 (+60.3%)
|
42.51
est: 28.03 (+51.7%)
|
54.89
est: 58.55 (-6.3%)
|
20.20
est: 21.50 (-6.0%)
|
27.94
est: 27.65 (+1.0%)
|
37.29
est: 34.70 (+7.5%)
|
52.65
52.65 – 52.65
+51.7% YoY
|
64.95
64.95 – 64.95
+23.4% YoY
|
82.40
82.40 – 82.40
+26.9% YoY
|
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-18 | B+ | 3/5 | 4/5 | 4/5 | 5/5 | 1/5 | 2/5 | 3/5 |
| 2026-05-15 | C | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-05-14 | C | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-05-13 | C | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-05-12 | C | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-05-11 | C | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-05-08 | C | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-05-07 | C | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-05-06 | C | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-05-05 | C | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-05-04 | C | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-04-30 | C | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-04-29 | C | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-04-28 | C | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-04-27 | C | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-04-24 | C | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-04-23 | C | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-04-22 | C | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-04-21 | C | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-04-20 | C | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-04-17 | C | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-04-16 | C | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
ETF Ownership
This company is not held by any ETF in our universe.
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Uma Shankar Bhartia | Chairman & MD | 152M | male |
| Pragya Bhartia Barwale | Executive Director | 60M | female |
| Alok Singhal | Whole-time Director | 9M | male |
| Sudhir Agarwal | President Operations | 8M | male |
| Dev Chander Jha | Chief Human Resources Officer | — | male |
| Madhup Misra | Head of Account & Admin | — | male |
| Atul Govil | Chief Technology Officer and Head of SAP & IT | — | male |
| Rupark Sarswat | Chief Executive Officer | — | male |
| Anand Singhal | Chief Financial Officer | — | male |
| Ankur Jain | Head of Legal, Compliance Officer & Company Secretary | — | male |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for INDIAGLYCO.NS
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
